Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1849卷 / 1期

关键词：

D O I：

10.1007/s40278-021-93636-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：252 / 252

相关论文

共 50 条

[1] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2022, 1891 (1) : 175 - 175
[2] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2021, 1864 (1) : 203 - 203
[3] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2022, 1929 (1) : 360 - 360
[4] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2018, 1697 (1) : 213 - 213
[5] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2020, 1801 (1) : 155 - 155
[6] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2022, 1924 (1) : 262 - 262
[7] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1685 (1) : 117 - 117
[8] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 8 case reports
Reactions Weekly, 2020, 1791 (1) : 153 - 153
[9] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 2 case reports
Reactions Weekly, 2023, 1960 (1) : 248 - 248
[10] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 10 case reports
Reactions Weekly, 2021, 1840 (1) : 227 - 227

← 1 2 3 4 5 →